skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Cannabidiol (CBD) is being looked at more and more by health, beauty and wellness companies for its use in new OTC drugs, cosmetics and food supplements. It is highly controversial because while CBD has many natural health benefits for treating a variety of conditions and symptoms, it is the active ingredient extracted from cannabis which comes from hemp plants, and therefore has a number of regulatory and legal challenges for its use, but also offers some new market opportunities.

HBW Insight has been closely monitoring and reporting on the developments of CBD across the global consumer healthcare industry, which can be accessed from the timeline of articles below:

 

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: